Your browser doesn't support javascript.
loading
Self-amplifying RNA COVID-19 vaccine.
Wayne, Christopher J; Blakney, Anna K.
Affiliation
  • Wayne CJ; Michael Smith Laboratories, School of Biomedical Engineering, University of British Columbia, BC, Canada.
  • Blakney AK; Michael Smith Laboratories, School of Biomedical Engineering, University of British Columbia, BC, Canada. Electronic address: anna.blakney@msl.ubc.ca.
Cell ; 187(8): 1822-1822.e1, 2024 Apr 11.
Article in En | MEDLINE | ID: mdl-38608649
ABSTRACT
In November 2023, Japan's Ministry of Health, Labour and Welfare granted regulatory approval of ARCT-154, a self-amplifying RNA COVID-19 vaccine developed by Arcturus Therapeutics. Clinical trials showed comparable safety and efficacy using a lower dose compared to the mRNA vaccine BNT162b2. To view this Bench-to-Bedside, open or download the PDF.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / MRNA Vaccines Limits: Humans Language: En Journal: Cell Year: 2024 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / MRNA Vaccines Limits: Humans Language: En Journal: Cell Year: 2024 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos